Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections
Objective: The objective of this analysis was to evaluate the cost-effectiveness of imipenem/cilastatin/relebactam compared to colistin-imipenem in the treatment of hospitalized patients with Gram-negative bacterial infections caused by imipenem-resistant pathogens. The perspective was both that of...
| Главные авторы: | , , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
AboutScience Srl
2023-04-01
|
| Серии: | Global & Regional Health Technology Assessment |
| Предметы: | |
| Online-ссылка: | https://journals.aboutscience.eu/index.php/grhta/article/view/2488 |